BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28367341)

  • 41. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations.
    Zanella A; Bianchi P
    Baillieres Best Pract Res Clin Haematol; 2000 Mar; 13(1):57-81. PubMed ID: 10916678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Splenectomy in hereditary hemolytic anemia: 82 Tunisian cases].
    Hafsia R; Zriba S; Gouider E; Ben Salah N; Borji W; Zaouche A
    Tunis Med; 2009 May; 87(5):323-7. PubMed ID: 19927762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
    Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hereditary spherocytosis.
    Bajracharya BL; Giri A; Baral MR
    Kathmandu Univ Med J (KUMJ); 2004; 2(2):145-8. PubMed ID: 15821383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Partial pyruvate kinase deficiency aggravates the phenotypic expression of band 3 deficiency in a family with hereditary spherocytosis.
    van Zwieten R; van Oirschot BA; Veldthuis M; Dobbe JG; Streekstra GJ; van Solinge WW; Schutgens RE; van Wijk R
    Am J Hematol; 2015 Mar; 90(3):E35-9. PubMed ID: 25388786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of five discriminating indexes to distinguish Beta-Thalassemia Trait from Iron Deficiency Anaemia.
    Ullah Z; Khattak AA; Ali SA; Hussain J; Noor B; Bano R; Jan Mahsud MA
    J Pak Med Assoc; 2016 Dec; 66(12):1627-1631. PubMed ID: 28179703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
    Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucose 6-phosphate dehydrogenase deficiency and red cell membrane defects: additive or synergistic interaction in producing chronic haemolytic anaemia.
    Alfinito F; Calabro V; Cappellini MD; Fiorelli G; Filosa S; Iolascon A; Miraglia del Giudice E; Perrotta S; Migliorati R; Vallone D
    Br J Haematol; 1994 May; 87(1):148-52. PubMed ID: 7947239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular diagnosis of unexplained haemolytic anaemia using targeted next-generation sequencing panel revealed (p.Ala337Thr) novel mutation in GPI gene in two Indian patients.
    Kedar PS; Gupta V; Dongerdiye R; Chiddarwar A; Warang P; Madkaikar MR
    J Clin Pathol; 2019 Jan; 72(1):81-85. PubMed ID: 30337328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and Molecular Spectrum of Glucose-6-Phosphate Isomerase Deficiency. Report of 12 New Cases.
    Fermo E; Vercellati C; Marcello AP; Zaninoni A; Aytac S; Cetin M; Capolsini I; Casale M; Paci S; Zanella A; Barcellini W; Bianchi P
    Front Physiol; 2019; 10():467. PubMed ID: 31133865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Erroneous diagnosis of iron deficiency anemia].
    Richter S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(5):781-3. PubMed ID: 2481626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary arterial hypertension after splenectomy for hereditary spherocytosis.
    Smedema JP; Louw VJ
    Cardiovasc J Afr; 2007; 18(2):84-9. PubMed ID: 17497044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Spectrum of
    Chonat S; Risinger M; Sakthivel H; Niss O; Rothman JA; Hsieh L; Chou ST; Kwiatkowski JL; Khandros E; Gorman MF; Wells DT; Maghathe T; Dagaonkar N; Seu KG; Zhang K; Zhang W; Kalfa TA
    Front Physiol; 2019; 10():815. PubMed ID: 31333484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias.
    Agarwal AM; Nussenzveig RH; Reading NS; Patel JL; Sangle N; Salama ME; Prchal JT; Perkins SL; Yaish HM; Christensen RD
    Br J Haematol; 2016 Sep; 174(5):806-14. PubMed ID: 27292444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hereditary spherocytosis: clinical characteristics and treatment with splenectomy].
    Jonte F; Ramírez A; Medina J; García Gala J; Rosón C; Corte JR; Vargas M; Pérez Lozana L
    Sangre (Barc); 1995 Feb; 40(1):45-8. PubMed ID: 7716671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dehydrated hereditary stomatocytosis: clinical perspectives.
    Frederiksen H
    J Blood Med; 2019; 10():183-191. PubMed ID: 31308777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Red cell membrane disorders.
    Narla J; Mohandas N
    Int J Lab Hematol; 2017 May; 39 Suppl 1():47-52. PubMed ID: 28447420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Current management of thalassemia intermedia].
    Thuret I
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictive value of MCV/RBC count ratio to discriminate between iron deficiency anaemia and beta thalassaemia trait.
    Afroz M; Shamsi TS; Syed S
    J Pak Med Assoc; 1998 Jan; 48(1):18-9. PubMed ID: 9610082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach.
    Kedar PS; Harigae H; Ito E; Muramatsu H; Kojima S; Okuno Y; Fujiwara T; Dongerdiye R; Warang PP; Madkaikar MR
    Int J Hematol; 2019 Nov; 110(5):618-626. PubMed ID: 31401766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.